PYC Therapeutics Limited (PYC.AX)
AUD 1.03
(-2.37%)
AUD 1.03
(-2.37%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -38.11 Million AUD | 0.36% |
| 2023 | -38.25 Million AUD | -30.35% |
| 2022 | -29.39 Million AUD | -38.46% |
| 2021 | -21.03 Million AUD | -131.69% |
| 2020 | -8.88 Million AUD | -31.32% |
| 2019 | -6.97 Million AUD | 28.03% |
| 2018 | -9.63 Million AUD | -130.84% |
| 2017 | -4.19 Million AUD | 28.01% |
| 2016 | -6.1 Million AUD | -20.9% |
| 2015 | -4.82 Million AUD | 2.05% |
| 2014 | -4.92 Million AUD | 15.58% |
| 2013 | -5.04 Million AUD | -50.66% |
| 2012 | -3.86 Million AUD | -8.61% |
| 2011 | -3.56 Million AUD | 22.5% |
| 2010 | -4.59 Million AUD | -70.55% |
| 2009 | -3.58 Million AUD | 51.2% |
| 2008 | -5.52 Million AUD | -18.31% |
| 2007 | -4.66 Million AUD | -29.98% |
| 2006 | -3.59 Million AUD | -111.49% |
| 2005 | -1.69 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - AUD | -55.05% |
| 2024 Q2 | -24 Million AUD | 0.0% |
| 2024 Q4 | -23.01 Million AUD | 0.0% |
| 2023 Q4 | -18.72 Million AUD | 0.0% |
| 2023 FY | - AUD | -30.35% |
| 2023 Q2 | -19.95 Million AUD | 0.0% |
| 2022 FY | - AUD | -38.46% |
| 2022 Q4 | -17.34 Million AUD | 0.0% |
| 2022 Q2 | -12.14 Million AUD | 0.0% |
| 2021 FY | - AUD | -131.69% |
| 2021 Q2 | -7.55 Million AUD | 0.0% |
| 2021 Q4 | -10.58 Million AUD | 0.0% |
| 2020 Q4 | -4.79 Million AUD | 0.0% |
| 2020 FY | - AUD | -31.32% |
| 2020 Q2 | -4.36 Million AUD | 0.0% |
| 2019 Q4 | -3.11 Million AUD | 0.0% |
| 2019 FY | - AUD | 28.03% |
| 2019 Q2 | -3.85 Million AUD | 0.0% |
| 2018 Q2 | -5.72 Million AUD | 0.0% |
| 2018 FY | - AUD | -130.84% |
| 2018 Q4 | -3.91 Million AUD | 0.0% |
| 2017 Q4 | -3.73 Million AUD | 0.0% |
| 2017 FY | - AUD | 28.01% |
| 2017 Q2 | -461.17 Thousand AUD | 0.0% |
| 2016 Q2 | -2.83 Million AUD | 0.0% |
| 2016 FY | - AUD | -20.9% |
| 2016 Q4 | -3.26 Million AUD | 0.0% |
| 2015 Q2 | -2.02 Million AUD | 0.0% |
| 2015 FY | - AUD | 2.05% |
| 2015 Q4 | -2.79 Million AUD | 0.0% |
| 2014 Q2 | -2.09 Million AUD | 0.0% |
| 2014 Q4 | -2.82 Million AUD | 0.0% |
| 2014 FY | - AUD | 15.58% |
| 2013 Q3 | -1.26 Million AUD | 57.04% |
| 2013 Q2 | -2.93 Million AUD | -216.69% |
| 2013 Q1 | -927.05 Thousand AUD | 0.0% |
| 2013 FY | - AUD | -50.66% |
| 2013 Q4 | -2.18 Million AUD | -73.06% |
| 2012 Q4 | -927.05 Thousand AUD | 0.0% |
| 2012 Q2 | -927.05 Thousand AUD | -7.47% |
| 2012 Q3 | -927.05 Thousand AUD | 0.0% |
| 2012 FY | - AUD | -8.61% |
| 2012 Q1 | -862.65 Thousand AUD | 0.0% |
| 2011 FY | - AUD | 22.5% |
| 2011 Q2 | -862.65 Thousand AUD | 23.42% |
| 2011 Q3 | -862.65 Thousand AUD | 0.0% |
| 2011 Q4 | -862.65 Thousand AUD | 0.0% |
| 2011 Q1 | -1.12 Million AUD | 0.0% |
| 2010 Q1 | -1.09 Million AUD | 0.0% |
| 2010 FY | - AUD | -70.55% |
| 2010 Q4 | -1.12 Million AUD | 0.0% |
| 2010 Q2 | -1.12 Million AUD | -2.95% |
| 2010 Q3 | -1.12 Million AUD | 0.0% |
| 2009 Q1 | -1.1 Million AUD | 0.0% |
| 2009 Q2 | -1.09 Million AUD | 1.3% |
| 2009 Q3 | -1.09 Million AUD | 0.0% |
| 2009 FY | - AUD | 51.2% |
| 2009 Q4 | -1.09 Million AUD | 0.0% |
| 2008 Q4 | -1.1 Million AUD | 0.0% |
| 2008 FY | - AUD | -18.31% |
| 2008 Q1 | -965.59 Thousand AUD | 0.0% |
| 2008 Q2 | -1.1 Million AUD | -14.81% |
| 2008 Q3 | -1.1 Million AUD | 0.0% |
| 2007 Q3 | -965.59 Thousand AUD | 0.0% |
| 2007 FY | - AUD | -29.98% |
| 2007 Q4 | -965.59 Thousand AUD | 0.0% |
| 2007 Q2 | -965.59 Thousand AUD | 9.32% |
| 2007 Q1 | -1.06 Million AUD | 0.0% |
| 2006 Q4 | -1.06 Million AUD | 0.0% |
| 2006 Q2 | -1.06 Million AUD | -34.17% |
| 2006 Q3 | -1.06 Million AUD | 0.0% |
| 2006 FY | - AUD | -111.49% |
| 2006 Q1 | -793.66 Thousand AUD | 0.0% |
| 2005 Q3 | -793.66 Thousand AUD | 0.0% |
| 2005 Q2 | -793.66 Thousand AUD | 0.0% |
| 2005 FY | - AUD | 0.0% |
| 2005 Q4 | -793.66 Thousand AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AdAlta Limited | -5.3 Million AUD | -618.833% |
| Acrux Limited | -7.93 Million AUD | -380.615% |
| Actinogen Medical Limited | -12.92 Million AUD | -195.001% |
| AnteoTech Limited | -11.57 Million AUD | -229.424% |
| Argenica Therapeutics Limited | -1.89 Million AUD | -1908.734% |
| Arovella Therapeutics Limited | -8.83 Million AUD | -331.528% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -2516.77% |
| Alterity Therapeutics Limited | -19.57 Million AUD | -94.759% |
| Amplia Therapeutics Limited | -4.55 Million AUD | -735.985% |
| Avecho Biotechnology Limited | -3.24 Million AUD | -1075.557% |
| Bio-Gene Technology Limited | -2.97 Million AUD | -1181.267% |
| Biome Australia Limited | -1.57 Million AUD | -2315.177% |
| Biotron Limited | -5.04 Million AUD | -656.293% |
| Botanix Pharmaceuticals Limited | -13.91 Million AUD | -173.845% |
| BTC Health Limited | 1.05 Million AUD | 3712.055% |
| Chimeric Therapeutics Limited | -11.29 Million AUD | -237.33% |
| CSL Limited | 4.73 Billion AUD | 100.805% |
| Clarity Pharmaceuticals Ltd | -44.64 Million AUD | 14.626% |
| Clinuvel Pharmaceuticals Limited | 51.86 Million AUD | 173.497% |
| Cynata Therapeutics Limited | -9.95 Million AUD | -283.083% |
| Dimerix Limited | -24.95 Million AUD | -52.723% |
| EZZ Life Science Holdings Limited | 10.37 Million AUD | 467.382% |
| Hexima Limited | -995.54 Thousand AUD | -3728.82% |
| Island Pharmaceuticals Limited | -2.81 Million AUD | -1252.589% |
| Immuron Limited | -6.19 Million AUD | -515.558% |
| Immutep Limited | -42.87 Million AUD | 11.097% |
| Imugene Limited | -147.97 Million AUD | 74.241% |
| Invex Therapeutics Ltd | -720.44 Thousand AUD | -5190.864% |
| Memphasys Limited | -3.3 Million AUD | -1052.381% |
| Nanollose Limited | -1.14 Million AUD | -3220.631% |
| Neuren Pharmaceuticals Limited | 199.26 Million AUD | 119.129% |
| Noxopharm Limited | -5.94 Million AUD | -541.117% |
| NeuroScientific Biopharmaceuticals Limited | -1.79 Million AUD | -2022.021% |
| Nyrada Inc. | -4.59 Million AUD | -729.327% |
| Orthocell Limited | -11.68 Million AUD | -226.318% |
| PharmAust Limited | -9.45 Million AUD | -303.287% |
| Patrys Limited | -3.49 Million AUD | -991.52% |
| Paradigm Biopharmaceuticals Limited | -64.53 Million AUD | 40.939% |
| Proteomics International Laboratories Limited | -7.88 Million AUD | -383.276% |
| Prescient Therapeutics Limited | -7.18 Million AUD | -430.464% |
| Race Oncology Limited | -14.2 Million AUD | -168.37% |
| Radiopharm Theranostics Limited | -45.37 Million AUD | 15.997% |
| Recce Pharmaceuticals Ltd | -21.35 Million AUD | -78.502% |
| Starpharma Holdings Limited | -12.57 Million AUD | -203.073% |
| Telix Pharmaceuticals Limited | 22.96 Million AUD | 265.974% |
| Tissue Repair Ltd | -5.77 Million AUD | -560.045% |
| Zelira Therapeutics Limited | -36.44 Million AUD | -4.6% |